Xeris Biopharma Inc. (XERS)

The total Delta Exposure (DEX) for XERS across all expirations shows 54,438.88 net shares that market makers must hedge, with 55,246.56 from calls and 807.68 from puts. The put-call delta ratio of 0.01 shows bullish positioning with call dominance, potentially providing upward momentum but leaving the market vulnerable to sharp pullbacks. The largest delta concentration at Oct 17, 25 with 35,653.33 net DEX represents significant hedging pressure that may cap upside moves. The nearest expiration on Sep 19, 25 carries positive delta requiring market makers to short shares, potentially creating resistance.